ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Haematological Malignancies
Leukaemia and Myeloma
Clinical Practice Guidelines
Latest ESMO videos
Featured medwireNews
Daratumumab Shows Clinical Benefit in Combination With Standard of Care in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
2-Year ZUMA-1 Results Add Support For Axicabtagene Ciloleucel In Refractory Large B-Cell Lymphoma
High Response Rates With Tisagenlecleucel In Adult Refractory DLBCL Patients
Ibrutinib Regimens Achieve ‘Superior’ PFS For Treatment-Naïve CLL in Older Patients
Ibrutinib–Rituximab Improves Waldenström’s Macroglobulinemia PFS
E-Learning
ESMO E-Learning: Open Questions in the Treatment of Follicular Lymphoma
ESMO E-Learning: Treatment of Multiple Myeloma Patients
ESMO E-Learning: Chronic Lymphocytic Leukaemia (CLL): State-of-the-art
ESMO E-Learning: Mantle Cell Lymphoma
ESMO E-Learning: Double-Hit Lymphomas
Meeting resources
Update in the management of high-grade NHL
Presenter: A. Stathis, CH
Session: Spotlight Session 1
Resources:
ESMO Course
8th ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology
Limassol
Precision hematopoietic stem cell replacement therapy
Presenter: Judith Anne Shizuru
Session: Haematological malignancies: Updates
Resources:
Presentation
Webcast
Engineered mAbs in haematological malignancies
Presenter: Helmut Salih
Session: Haematological malignancies: Updates
Resources:
Presentation
Webcast
Development and commercialisation of a first-in-class chimeric antigen receptor T-cell product for large cell lymphoma
Presenter: John Rossi
Session: Innovative technological development
Resources:
Presentation
Webcast